HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yee, E. S. Articles by Ebert, P. A. Search for Related Content PubMed PubMed Citation Articles by Yee, E. S. Articles by Ebert, P. A.

The Annals of Thoracic Surgery, Vol 42, 488-493, Copyright © 1986 by The Society of Thoracic Surgeons

ARTICLES

Infant coarctation: a spectrum in clinical presentation and treatment

ES Yee, SJ Soifer, K Turley, ED Verrier, NH Fishman and PA Ebert

Between 1975 and 1985, 125 infants 2 to 365 days old (majority, 30 days old or less) with coarctation of the aorta underwent surgical repair. Forty-seven patients (38%) had severe congestive heart failure (CHF), metabolic acidosis, and poor systemic perfusion. The predominant operative technique was synthetic patch aortoplasty (100 patients); the remaining 25 had an end-to-end anastomosis. There were no operative deaths. Perioperative complications were minimized with the synthetic patch technique (less than 15%). For patients surviving at least 3 months after repair, the arm-leg systolic blood pressure gradient was relieved in 82% (71/87) of the patients having patch aortoplasty versus 65% (15/23) of the patients with end-to-end anastomosis. Although the rate of reoperation between the two groups was similar (patch, 5 [6%]; end-to-end, 3 [13%], two of the reoperations in the patch group were for preexisting hypoplastic transverse aortic arch. Late deaths (20 patients, 16%) were due to other major associated cardiac anomalies. Patch aneurysms have not occurred. Expedient use of synthetic patch aortoplasty has decreased perioperative complications, relieved coarctation gradients for CHF, increased early survival even in the presence of complex or associated cardiac anomalies, and has an acceptable rate of recurrent coarctation (6 to 13%).

This article has been cited by other articles:

				R. J. Walhout, J. C. Lekkerkerker, G. H. Oron, F. J. Hitchcock, E. J. Meijboom, and G. B.W.E. Bennink Comparison of polytetrafluoroethylene patch aortoplasty and end-to-end anastomosis for coarctation of the aorta J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 521 - 528. [Abstract] [Full Text] [PDF]

				A. Jelly, A. Jelly, M. O. Galal, F. Al Fadley, M. de Moor, and Z. Al Halees Influence of Associated Defects and Type of Surgery in Neonatal Aortic Coarctation Asian Cardiovasc Thorac Ann, June 1, 1999; 7(2): 115 - 120. [Abstract] [Full Text] [PDF]

				C. L. Backer, K. Paape, V. R. Zales, T. J. Weigel, and C. Mavroudis Coarctation of the Aorta : Repair With Polytetrafluoroethylene Patch Aortoplasty Circulation, November 1, 1995; 92(9): 132 - 136. [Abstract] [Full Text]